RxDoctor Payments Data

Maria Zweig, MD

Obstetrics & Gynecology · San Juan, PRNPI 1356303549

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $1,500 of the $2,401 with a category attached, or 62.5%. Merck accounts for 71.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $1,693 and has fallen 93.0% since, to $119 in 2025. Among obstetrics & gynecology clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,401in general payments, 2019–2025

Across 26 payments — averaging $92.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$2K
  • Amgen$241
  • Hologic Sales And Service, LLC$124
  • BD$124
  • Johnson And Johnson International$100
  • PBG Puerto Rico LLC$77
  • plus $24 from 1 others

What the payments were for

  • Consulting fees$1,50062%
  • Food & beverage$90138%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merck5$1,711
Amgen7$241
Hologic Sales And Service, LLC5$124
BD2$124
Johnson And Johnson International1$100
PBG Puerto Rico LLC5$77
Biogen1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,401 in reported general payments places this provider in the 90th percentile of 333 obstetrics & gynecology providers in Puerto Rico.

See all obstetrics & gynecology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$45,022
Medicare patients
147
Services billed
435

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProliaDenosumab25$44,078
Estradiol212$17,417
ProgesteroneProgesterone, Micronized125$5,271
Tolterodine Tartrate ErTolterodine Tartrate48$3,790
Risedronate Sodium41$2,230
Metronidazole72$1,669
Alendronate Sodium82$1,158
Terconazole32$1,006
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip32$692
ValacyclovirValacyclovir Hcl18$190
Atorvastatin Calcium11$111
Fluconazole11$55

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenProlia$241$44,07825 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 333 obstetrics & gynecology providers in Puerto Rico.

Other obstetrics & gynecology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →